Clevudine Demonstrates Potent Antiviral Activity in Naïve Chronic Hepatitis B Patients
Author(s) -
June Sung Lee,
Eun Taek Park,
Seung Sik Kang,
Eun Sil Gu,
Jongsun Kim,
Dong Seob Jang,
Kyoung Seog Lee,
Jae-Su Lee,
Nung Hwa Park,
Chang Hwang Bae,
Soon Koo Baik,
Byeong Jeon Yu,
Soon Hyung Lee,
Eun Jong Lee,
Sung Il Park,
Myoung Bae,
Jung Woo Shin,
Jae Hong Choi,
Chul Hoi Gu,
Sin Kil Moon,
Gab Jin Chun,
Ju Hyun Kim,
Hong Soo Kim,
Sung-Kyu Choi
Publication year - 2009
Publication title -
intervirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.641
H-Index - 61
eISSN - 1423-0100
pISSN - 0300-5526
DOI - 10.1159/000264197
Subject(s) - hbeag , medicine , chronic hepatitis , hepatitis b virus , serology , hepatitis b , virology , gastroenterology , immunology , virus , hbsag , antibody
Clevudine has demonstrated antiviral potency in the treatment of naïve chronic hepatitis B patients in pivotal studies. The objectives of this study were to evaluate the safety and efficacy of a 1-year treatment with clevudine in chronic hepatitis B patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom